The study of Sema3A and its receptors, such as plexinsA1-A4 (PLXNA1-A4) and neuropilin-1 (NRP1) in PC, demonstrates that SEMA3A had no impact on the growth or survival of pancreatic tumor cells and was upregulated in PC. This evidence concerns the gene NRP1 and pachyonychia congenita.